Chondrosarcoma overview: Difference between revisions

Jump to navigation Jump to search
Suveenkrishna Pothuru (talk | contribs)
No edit summary
Suveenkrishna Pothuru (talk | contribs)
No edit summary
Line 12: Line 12:
==Pathophysiology==
==Pathophysiology==
On gross pathology, Greyish-white lobulated mass, [[necrosis]], [[calcification]], mucoid degeneration are characteristic findings of chondrosarcoma. On microscopic histopathological analysis abnormal [[cartilage]], increased cellularity, nuclear atypia are characteristic findings of chondrosarcoma. Chondrosarcoma may be divided into three grades based on cancer cells morphology under microscope and growth rate of [[tumor]].
On gross pathology, Greyish-white lobulated mass, [[necrosis]], [[calcification]], mucoid degeneration are characteristic findings of chondrosarcoma. On microscopic histopathological analysis abnormal [[cartilage]], increased cellularity, nuclear atypia are characteristic findings of chondrosarcoma. Chondrosarcoma may be divided into three grades based on cancer cells morphology under microscope and growth rate of [[tumor]].
==Causes==
There are no established causes for chondrosarcoma.


==Differential Diagnosis==
==Differential Diagnosis==

Revision as of 19:40, 31 August 2015

Chondrosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chondrosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chondrosarcoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chondrosarcoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chondrosarcoma overview

CDC on Chondrosarcoma overview

Chondrosarcoma overview in the news

Blogs on Chondrosarcoma overview

Directions to Hospitals Treating Chondrosarcoma

Risk calculators and risk factors for Chondrosarcoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

A chondrosarcoma is a particular cancer of the bone. Chondrosarcoma is a cartilage based tumor and is in a category of cancers called sarcomas. Chondrosarcoma is a rare cancer that can affect people (and animals) of any age. The aggressiveness of chondrosarcoma is graded based on how fast it grows and its likelihood to metastasize or spread to other parts of the body. Grade 1 is a low grade (slow growing) cancer, and grades 2 and 3 are higher grades (fast growing) cancers. Depending on the grading system used by your medical facility, it's also possible to have grade 4 which would be even more aggressive than lower grade tumors. The most common bones for chondrosarcoma to grow are the pelvic and shoulder bones along with the superior regions of the arms and legs. [2] But they can also be found in any bones of the body, even in the base of the skull.

Nearly all chondrosarcoma patients appear to be in good health. Since it is not like other cancers, it doesn't affect the whole system. Many patients are not aware that there is a tumor growing inside them until there is a noticeable lump or pain. Sometimes a patient has no symptoms and no awareness of any lump and perhaps, by having a test for something else gets diagnosed accidentally. Sometimes an unexpected fracture will be the first indication of a bone tumor.[3]

Classification

Chondrosarcoma may be classified into six subtypes based on topographical location of tumor, histological characteristics, makeup of surrounding matrix material.

Pathophysiology

On gross pathology, Greyish-white lobulated mass, necrosis, calcification, mucoid degeneration are characteristic findings of chondrosarcoma. On microscopic histopathological analysis abnormal cartilage, increased cellularity, nuclear atypia are characteristic findings of chondrosarcoma. Chondrosarcoma may be divided into three grades based on cancer cells morphology under microscope and growth rate of tumor.

Causes

There are no established causes for chondrosarcoma.

Differential Diagnosis

Chondrosarcoma must be differentiated from other diseases such as chondroma, enchondroma, synovial chondromatosis, osteosarcoma.

Epidemiology and Demographics

Chondrosarcoma is the second most common malignant primary tumor of bone. Men are slightly more affected with liposarcoma than women. It is most frequent in middle-aged and older adults.

Risk factors

Common risk factors in the development of chondrosarcoma are benign cartilage tumors such as Enchondromas, Osteochondromas, Multiple exostoses, Ollier's disease, Maffucci's syndrome.

Natural History, Complications and Prognosis

Complications that can develop as a result of chondrosarcoma are metastasis and recurrence. The prognosis of chondrosarcoma is good with treatment. Chondrosarcoma is associated with a 5 year survival rate of 75%. The presence of grade 3 lesions are associated with a particularly poor prognosis.

Diagnosis

History and Symptoms

The most common symptoms of chondrosarcoma include pain and swelling in the area of tumor.

Physical Examination

Physical examination findings will depend on the location of the chondrosarcoma. Common physical examination findings of chondrosarcoma are localized swelling and tenderness.

Laboratory Findings

There are no specific laboratory tests for the diagnosis of chondrosarcoma.

CT

On CT scan, chondrosarcoma is characterized by matrix calcification, endosteal calcification, cortical breach, heterogenous contrast enhancement.

MRI

On MRI, chondrosarcoma is characterized by low to intermediate signal on T1, very high intensity in calcified portions on T2, and moderate to intense contrast enhancement on T1 contrast.

Treatment

Medical Therapy

Chemotherapy and radiotherapy are indicated for chondrosarcoma as adjuvant therapy. Proton therapy is a new kind of radiotherapy showing promising results with local tumor control at over 80%.

Surgery

The predominant therapy for chondrosarcoma is surgical resection. Adjunctive chemotherapy and radiation may be required.

References


Template:WikiDoc Sources